Literature DB >> 3029193

Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine.

T L van der Loos, E R Lambrecht, J C Lambers.   

Abstract

A 63-year-old man with a glucagonoma syndrome is described. The diagnosis was confirmed by necrolytic migratory erythema, which is the most distinctive feature of the clinical syndrome. There was no chance of operative resection of the tumor because of liver metastases at the time of diagnosis. The patient was treated with dacarbazine. During this treatment the skin lesions disappeared completely.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029193     DOI: 10.1016/s0190-9622(87)70063-2

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors.

Authors:  Daniela Mueller; Sebastian Krug; Moushumee Majumder; Anja Rinke; Thomas Matthias Gress
Journal:  BMC Cancer       Date:  2016-08-18       Impact factor: 4.430

2.  Necrolytic migratory erythema associated with glucagonoma: a report of 2 cases.

Authors:  Renata Câmara Teixeira; Marcello Menta Simonsen Nico; Anelise Casillo Ghideti
Journal:  Clinics (Sao Paulo)       Date:  2008-04       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.